Tag: NCT03180307

Home / NCT03180307

Categories

Pafolacianine is approved for identifying malignant ovarian cancer lesions

Jan 2022: Pafolacianine (Cytalux, On Target Laboratories, LLC), an optical imaging agent, has been licenced by the Food and Drug Administration for adult patients with ovarian cancer as an adjuvant f...
nct03180307

Scan the code